# Veeda Clinical Research Limited
**ISIN:** INE01HQ01026
**Canonical URL:** https://polemarch.in/invest/veeda-clinical-research-limited
**Type:** Unlisted
**Sector:** General / Unlisted
**Market cap bucket:** Unspecified
**Current quoted price:** ₹0.00 per share

> This is a plain-text / markdown summary of the Polemarch share-detail page, generated server-side for AI retrieval. The live interactive page at the canonical URL above has the same data plus charts, filters, and buy flow.

## Company profile

## Key ratios (as of FY2024, yearly)
### Liquidity Ratios
- **Working Capital:** 4.5146
- **Current Ratio:** 1.08815787
- **Quick Assets:** 54.946
- **Quick Ratio:** 1.07294612
- **Cash Ratio:** 0.18327527
- **Working Capital To Sales:** 0.11612312
- **Defensive Interval Ratio:** 318.61783247
- **Net Working Capital to Assets:** 0.02212815

### Leverage Ratios
- **Total Debt:** 26.1685
- **Net Debt:** 16.7829
- **Debt to Equity:** 0.24571362
- **Debt to Assets:** 0.12826395
- **Debt To Capital:** 0.19724727
- **Equity Ratio:** 0.52200586
- **Financial Leverage:** 1.91568732
- **Interest Coverage:** 1.22329565
- **EBITDA Interest Coverage:** 4.87913669
- **Net Debt to EBITDA:** 2.35678477
- **Long Term Debt to Equity:** 0.22533146
- **Long Term Debt to Capital:** 0.18389429
- **Debt to EBITDA:** 3.67478339
- **Net Debt to Equity:** 0.15758592

### Profitability Ratios
- **Effective Tax Rate:** 1.10984965
- **NOPAT:** -0.19612556
- **Invested Capital:** 123.28290000000001
- **Gross Margin:** 0.95116481
- **EBITDA Margin:** 0.1831667
- **EBIT Margin:** 0.0459235
- **Pre Tax Margin:** 0.0083827
- **Net Margin:** -0.00092084
- **Return on Assets:** -0.00017547
- **Return on Equity:** -0.00033615
- **Return on Capital Employed:** 0.01168377
- **Return On Invested Capital:** -0.00159086
- **Pre-Tax ROE:** 0.00306009
- **Cash ROA:** 0.02886521
- **Return on Net Assets:** -0.00023428
- **Operating ROA:** 0.00875107

### Efficiency Ratios
- **Asset Turnover:** 0.19055762
- **Fixed Asset Turnover:** 2.04182094
- **Inventory Turnover:** 4.90359435
- **Receivables Turnover:** 3.21569065
- **Payables Turnover:** 0.58335115
- **Working Capital Turnover:** 8.6115492
- **Days Inventory Outstanding:** 74.43519464
- **Days Sales Outstanding:** 113.505943
- **Days Payables Outstanding:** 625.6951752
- **Cash Conversion Cycle:** -437.75403756
- **Equity Turnover:** 0.36504883
- **Capital Employed Turnover:** 0.29791843

### Cashflow Ratios
- **Operating Cash Flow to Sales:** 0.15147758
- **Operating Cash Flow to Net Income:** -164.5
- **Free Cash Flow:** 14.2221
- **Free Cash Flow Margin:** 0.36581639
- **Cash Flow to Debt:** 0.22504538
- **Cash Interest Coverage:** -4.59045912
- **FCF to Net Income:** -397.26536313
- **Capital Expenditure:** -8.333
- **Capex to Sales:** -0.21433881
- **Capex to Operating Cashflow:** -1.41498701
- **Dividend Payout Ratio:** 0
- **Retention Ratio:** 1

### Valuation Models
- **Enterprise Value:** 16.7829
- **P/S Ratio:** 0
- **EV / EBITDA:** 2.35678477
- **EV / Sales:** 0.43168449
- **EV / EBIT:** 9.40007841
- **EV to FCF:** 1.1800578
- **EV to Assets:** 0.08226077
- **EV to Capital Employed:** 0.10982833
- **EV to Invested Capital:** 0.13613324

### DuPont Analysis
- **DuPont: Tax Burden:** -0.10984965
- **DuPont: Interest Burden:** 0.18253613
- **DuPont: EBIT Margin:** 0.0459235
- **DuPont: Asset Turnover:** 0.19055762
- **DuPont: Equity Multiplier:** 1.91568732
- **DuPont ROE (5-step):** -0.00033615

### Earnings Quality
- **Accruals to Assets:** -0.02904068
- **Accruals to Net Income:** 165.5
- **Cash Earnings Coverage:** -164.5
- **Capex to Depreciation:** -1.56174448

## Recent price points (last 10)

| Date | Price (₹) |
|---|---:|
| 2026-04-16 | 448 |
| 2026-04-17 | 448 |
| 2026-04-18 | 448 |
| 2026-04-19 | 448 |
| 2026-04-20 | 448 |
| 2026-04-21 | 448 |
| 2026-04-22 | 448 |
| 2026-04-23 | 448 |
| 2026-04-24 | 467 |
| 2026-04-25 | 448 |

---
## Risk disclosure

Unlisted shares are illiquid and can lose their full value. They're illiquid, prices can swing sharply, and a quoted price is only as good as the next willing buyer at that level. Polemarch does not guarantee any return on any share. Talk to a SEBI-registered investment adviser before you put money in. Past performance is not a forecast of future returns.

Canonical (live): https://polemarch.in/invest/veeda-clinical-research-limited
Operator: Mithtech Innovative Solutions Pvt Ltd, Bengaluru, India.